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The ability to evaluate effects of factors on outcomes is increasingly important for a class of
studies that control some but not all of the factors. Although important advances have been
made in methods of analysis for such partially controlled studies, work on designs for such
studies has been limited. To help understand why, we review main designs that have been used
for such partially controlled studies. Based on the review, we give two complementary reasons
that explain the limited work on such designs, and suggest a new direction in this area.
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1. Introduction
In order to evaluate the effects of factors on an outcome, interest has been increasing for a
broad class of studies that can control the mechanism of assignment of some but not all of
the factors. Such “partially controlled studies” have their origin in economics, where they have
been evaluated traditionally with the method of instrumental variables (IV) (1). However, as the
use of partially controlled studies has expanded in medicine, public health, and social sciences,
it has created the need also for broader methods than IV, in order to address different target
quantities for estimation, to allow more plausible underlying assumptions, and also to allow
different modes of inference.
Partially controlled studies presently are important in the following three main categories.
First, a prospectively designed study respecting ethical concerns may be able to only control the
encouragement of participants to receive specific treatments, and leave to the participants the
choice of the treatment they will actually select. In this category belong, for example, random-
ized studies with noncompliance to treatment (e.g., (2)-(11)). Second, even if there is sufficient
ethical basis, the study may not have a priori a known mechanism by which to change directly
the factors of interest. In this second category belong, for example, studies examining path-
ways that mediate the effect that a controlled treatment has on a clinical outcome (e.g., (12)-
(16)). Finally, for studies that are not prospectively designed as controlled, it is still beneficial
if they can be framed in a template of a partially controlled study, in order to provide more
accurate evaluations of the factors of interest. This requires that a factor be controlled by some
system, and the mechanism of assignment (24) of that factor be ignorable by the investigator
(24), since, then, a distinction between the investigator and the system that actually controls the
factor is inessential for valid likelihood inference. In this category belong, for example, some
studies in economics that observe human behavior without an attempt to explicitly control it
(e.g., (17)-(18)) but where it is plausible to assume control of other factors related to that behav-
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ior. Such studies become more demanding when they need to handle a multitude of partially
controlled factors, such as mechanisms creating missing or undefined data (e.g., (19)-(22)).
The extended use of partially controlled studies, and the improvement in methods of their
evaluation given data, would imply that there should also exist better designs, for example, in
order to better focus on more informative subsets of the data, or to increase cost-effectiveness in
conducting the studies. However, study on more flexible designs in partially controlled studies
has been limited.
To help understand why, we review main designs that have been used for such studies. We
focus on designs that can be combined with relatively general measurements of each of the
factors at a single time, as the issues in these designs can then extend to longitudinal factors. In
the review in the next section, we examine the main problem each design attempts to address,
and we summarize briefly examples. For each example, we examine the reason for using
a template of a partially controlled study, the reason for the corresponding design, and the
statistical analysis. The examples reviewed are not all meant to be chronologically the first
ones using the corresponding design, but are chosen for their suitability to highlight the main
arguments, and because they share some assumptions commonly made with partially controlled
studies. The review confirms the limited work on designs even when making such assumptions.
Section 3 gives two main explanations for this limitation, and uses these explanations to suggest
a new direction of work in designs in this area.
2. Designs for partially controlled studies
2.1 Cohort design with completely randomized assignment
We discuss the design of a simple cohort in terms of a template introduced in Angrist, Imbens
and Rubin (7) for noncompliance, and later generalized for partially controlled studies (13).
This template is based on potential outcomes, (23), (24), that is, outcomes of a person that,
3
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before the study starts, are observable under different levels of a controlled factor. We use
this template in the context of a hypothetical study, in order to establish some terminology and
notation to make connections with the other designs.
The study controls the assignment of each of a group of consenting participants i to either
an experimental treatment (z = 1) or the standard treatment (z = 0). Suppose that the experi-
mental treatment has been developed to improve a clinical outcome Y by first trying to increase
levels of a variable E, for example, to regulate the expression level of a particular gene by tar-
geting its enhancer or promoter region. Because the levels of E are not controlled directly, but
are affected by the controlled factor z – the treatment, we call E a “partially controlled” factor.
Let Ei(1) = 1( or 0) indicate if the participant’s gene expression level is high (or low) two
months after assignment, if that participant is originally assigned to experimental treatment;
and let Ei(0) = 1(or 0) indicate the participant’s level of E two months after assignment, if
that participant is originally assigned to standard treatment. Also, let Y i(z) be the outcome of
interest (e.g., 1 year survival) if the participant is assigned to treatment z, z = 0, 1.
The goal is to examine the role that gene expression E has in the effect of treatment on
outcomes. To address this, it is first important to consider the principal stratification (13)
of participants defined by the joint values of the gene’s expression under the two treatments,
Si = (Ei(0), Ei(1)): participants whose expression would be low if assigned standard and
also if assigned experimental treatment, {i : Ei(0) = Ei(1) = 0}, whom we call “low-
expressed”; participants that would have a low expression level if assigned standard treatment
and that would have high expression level if assigned experimental treatment, {i : Ei(0) =
0 and Ei(1) = 1}, whom we call “responders” to the experimental treatment; participants that
would have a high expression level if assigned the standard and also if assigned the experimen-
tal treatment; {i : Ei(0) = Ei(1) = 1}, called “fully-expressed”; and participants who would
have a high expression if assigned standard but a low expression if assigned experimental treat-
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ment, {i : Ei(0) = 1 and Ei(1) = 0}, whom we call “special”.
Although a participant’s gene expression level can be affected by treatment, a participant’s
membership Si to the above principal strata is not affected by treatment. For this reason, the
substantive goal in studies with such structure for a partially controlled factor can often be to
estimate the causal effects that the treatment z has on the outcomes Y conditionally on some
of the principal strata S.
Addressing this goal is complicated by the fact that memberships to the principal strata
cannot all be directly observed, so it is important to consider simplifying assumptions on the
above template, and it is necessary to also describe the design mechanism for collecting the
observed data. A large part of work cited in Section 1 using this template makes some variants
of the following assumptions of instrumental variables (7).
Monotonicity. There are no “special” participants.
Exclusion Restriction. If for a participant, treatment does not affect the factor E, then treatment
does not affect the outcome Y , i.e., if Ei(0) = Ei(1) then Yi(0) = Yi(1).
Monotonicity is posited when assignment to the experimental treatment is designed to keep
the levels of the partially controlled factor E to be at least those that would be achieved under
standard treatment. Exclusion is posited when the experimental treatment has been designed
so as to have no other plausible way to affect the outcome Y except if it affects the factor E.
In the example where gene expression is the partially controlled factor, exclusion and
monotonicity can be made plausible by targeting, respectively, a specific mechanism and spe-
cific direction of that mechanism, as when a treatment targets the promoter or enhancer of a
specific gene in studies of prostate cancer (e.g., (25)). Note that such properties do not assume
that, if the treatment does affect expression for an individual, then it will have no side effect,
and side effects should also be studied as outcomes. Of course, depending on the application,
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it may be important to consider deviations from the above assumptions.
Figure 1 here
Under monotonicity, the “responders” are the only principal stratum for which the exper-
imental comparison between different treatments is a comparison between different gene ex-
pression levels. Also, under exclusion, the “responders” are the only principal stratum whose
outcome can be affected by treatment. For these reasons and under these assumptions, the effect
of treatment on outcome for “responders” in the population, E(Yi(1)−Yi(0) | Si = responder),
denoted here by δYresponder, often can quantify the target of estimation. In the gene expression
example, the magnitude of δYresponder will indicate how experimentally increasing expression
levels E of the targeted gene associates to achieving better clinical outcomes Y , and thus will
provide guidance on whether a more focused research is needed on that gene’s properties.
For the mechanism of observing data, a simple cohort randomized design assumes the
following.
Completely randomized assignment. Assignment to the experimental or standard treatment is
completely randomized, Zi⊥⊥ (Yi(z), Si)
Simple random sampling of participation. Study participants are a simple random sample from
a population of consenting participants.
The first assumption essentially implies that assignment is ignorable in the sense of Rubin
(24) without conditioning on other variables; the second assumption allows the results from the
study participants to be generalized in a simple way to a larger population. Figure 1 shows the
relation of observed data to potential outcomes and principal strata under these assumptions,
where Eobsi = Ei(Zi) and Y obsi = Yi(Zi) are the observed expression levels and outcomes.
Responders are not observed alone in either treatment arm, and estimation of δYresponder
needs to rely on its indirect relation to the observable data.
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Such a relation is obtained by decomposing the intention-to-treat effect of assignmed treat-
ment, δY = E(Yi(1)− Yi(0)), across principal strata as
∑
p E(Yi(1)− Yi(0) | Si = s)pr(Si =
s), which reduces to δY responderpr(Si = responder), giving
δYresponder = δY/pr(Si = responder). (2.1)
by exclusion and monotonicity, as in Angrist et al. (7). The assumptions imply that the
probability of being a responder equals the difference in the probabilities of having a high
gene expression when assigned experimental versus when assigned standard treatment, or
pr(Eobsi = 1 | Zi = 1) − pr(Eobsi = 1 | Zi = 0). The latter difference is estimable con-
sistently by the corresponding sample averages. Also, the effect of assigned treatment on all
participants, δY , is estimable directly from the difference in sample averages in the outcomes
of the participants assigned experimental vs. standard treatment. So, in this design, the ef-
fect on responders, δYresponder, can be estimated consistently by substituting simple sample
analogues of the quantities in the right side of (2.1).
The above template is often useful in studies that do not explicitly control treatment either,
but where using the template through some modifications can be justified and can lead to more
reliable inferences on the effect associated with the partially controlled factor.
2.2 Paired Availability Design
Often, a common concern is that the assignment mechanism of the controlled factor varies
systematically across strata of known variables that are also associated with the outcome and
the principal strata. This can be addressed by planning for a design that measures the known
variables conditionally on which the assignment can then be assumed ignorable. From the
standpoint of analysis, this design can then be addressed with methods of varying degrees of
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adjustments.
A simple such design that demonstrates the point is the paired availability design (PAD)
proposed in a study by Baker and Lindeman (26), prior to the more explicit template with
potential outcomes cited in Section 2.1 (see also Cuzick, Edwards, and Segnan (27) in the
setting of a multi-center randomized trial). The study’s goal was to evaluate the effect that
receiving epidural analgesia (EA) during women’s labor has on getting a Caesarean section
(CS). In this case, randomized clinical trials were difficult to be implemented. Alternatively,
the study could have compared the rate of CS among women who received EA to those who
did not. However, these two groups of women expectedly differed in baseline characteristics
in both observed and unobserved ways that related to the likelihood of having CS (26).
The study addressed the above issue by measuring availability of EA, in addition to actually
receiving it. In terms of the template of Section 2.1, the factor z is whether or not EA was
available to a woman at her hospital at the time she was giving birth; Ei(z) indicates whether
or not the woman actually would have received EA as a function of availability; and Yi(z) is
the indicator of getting a CS, for z = 0, 1. Because a woman could not receive EA if it was not
available, there are two principal strata S: women who would receive EA if it were available;
and women who would not receive EA no matter its availability.
The main problem here with the assumptions of the previous section focuses on complete
randomization. The availability of EA varied with the timing that hospitals started offering the
procedure. Hospitals, however, can differ systematically in both the relative frequency in which
they made EA available to women, and also in the characteristics associated with the likelihood
of the women receiving EA and having CS. This makes the assignment unconditionally not
ignorable.
The PAD addressed this problem by planning for and measuring the information on the
hospitals to which the women in the study gave birth. Availability of EA then was treated as a
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controlled factor, in the sense here that, conditionally on the hospital information, the rule used
by the hospitals for the actual timing of the availability is assumed ignorable by the investigator.
In this design, a “pair” is specific to each hospital and its two “members” are the two groups
of assignment, women when EA was less available and women when EA was more available
within each hospital.
The study analysed the design by first carrying out completely separate analyses within
each hospital, each analysis being analogous to that described at the end of the template in the
previous section. These analyses for hospital h produce estimates, say dYresponder,h, of the
effect δYresponder,h, which is now the effect that availability of EA has on the probability of
CS, for the women who would receive EA if it were available. To combine the results from
each hospital, the study used an average of dYresponder,h, weighted by the inverse estimated
variance of the estimated effects within each hospital. A generalized version of this analysis
of PAD has also been given (28), which allows different types of availability and multiple time
periods.
2.3 Matched pairs of assignment design
The full stratification and corresponding analyses in PAD is feasible when the strata are rela-
tively few. However, a finer stratification based on more than one covariate is often desirable.
Although this can be addressed with modelling, it can also be addressed with a design that
matches on covariates two participants assigned different treatments. This design is important
in partially controlled studies, as in other types of studies, for two reasons. First, the inves-
tigator may want to rely less on model assumptions of how the covariates relate to principal
strata and potential outcomes. Second, the investigator may need to limit cost by selecting for
follow-up a subset of the participants, and matching can help such selection. For each reason,
we review below a partially controlled study with the matched pairs of assignment design, the
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first using randomization inference and the second using likelihood inference.
Randomization inference.
Rosenbaum (29) provided an example of a matched pairs design from an earlier study
by Card and Krueger (30) on the effect that increase in minimum wage has on changes in
employment in the fast food industry. The original study had been designed around April 1992
when New Jersey increased its minimum hourly wage from $4.25 to $5.05. The original study
had collected wage and employment data on fast food restaurants in New Jersey (where the law
changed) and in neighbouring Pennsylvania (where the law did not change), before and after
the change in New Jersey’s law.
To estimate the effect of wage increases on employment, the study of Rosenbaum (29) used
the change in law as an instrumental variable. In terms of the template of Section 2.1, the “par-
ticipants” are restaurant units; the factor z for restaurant i is the indicator for whether the new
law would be applicable (in New Jersey) or not applicable (in Pennsylvania) to that restaurant
after April 1992; and Ei(z) and Yi(z) are, respectively, the log wage and log employment at the
restaurant after April 1992 if the new law were applicable (z = 1) or not applicable (z = 0)
to that restaurant. Although the study did not explicitly control the change of the law, it first
treated the change as controlled under the assumption of ignorability, but it also considered
nonignorable assumptions. Ignorability here means comparability between the restaurants to
which the new law was applicable and those to which the new law was not applicable.
The matched pairs approach in this study had a design, a model, and an analysis component.
The design created 66 matched pairs of restaurants, each pair having one from New Jersey
and one from the neighbouring area of eastern Pennsylvania. Within pairs, restaurants were
matched for restaurant chain and starting wages before the increase in New Jersey’s law. The
analysis with these data was based on a model on the potential outcomes and wages, and a
permutation inference on a robust estimate of the parameter characterizing the effect in that
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model. We examine the model and inference separately, to highlight their different roles for
this design.
The model is specific to each pair of the design. Let (Ep,1(0), Ep,1(1)), be the principal
stratum in (log) wages of unit “1” in pair p, and (Ep,2(0), Ep,2(1)) be that of unit “2” in pair
p, where “1” and “2” are randomly given labels. Similarly let (Yp,i(0), Yp,i(1)) be the potential
(log) employment values for unit i in pair p. The study’s model is:
Yp,i(z) = rp,i + βEp,i(z), which implies
(2.2)
Yp,i(1)− Yp,i(0) = β(Ep,i(1)− Ep,i(0)).
In analogy to the template of Section 2.1, the effect of interest β by the bottom expression
of (2.2) is defined through the principal strata (Ep,i(0), Ep,i(1)), as the ratio of the effect that
the law has on the increase in employment Y , per unit of effect that the law has in increasing
actual starting wage E. The bottom expression also clarifies that exclusion is assumed here as
defined in Section 2.1, although here E is continuous.
To estimate β, the study considers the within-pair p observed contrasts in outcome, dYp,
and in wage, dEp,
dYp =
⎧⎨
⎩
Yp,1(1)− Yp,2(0)
Yp,2(1)− Yp,1(0)
and dEp =
⎧⎨
⎩
Ep,1(1)− Ep,2(0)
Ep,2(1)− Ep,1(0)
if Zp = 1
if Zp = 0
where Zp is the indicator for unit “1” of the pair being subject to the new law. Model (2.2) then
implies that in matched pair p, dYp and dEp are related through
dYp − βdEp = (2Zp − 1)(rp,1 − rp,2) (2.3)
11
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Based on the above, the study proposed a permutation based inference by inverting a function
g({dYp − βdEp}), considering both ignorable and non-ignorable assignments within pairs;
we focus here on inference under ignorability. Such inference hypothesizes a value β∗; then
calculates (rp1−rp2) for each pair using in (2.3) the hypothesized β∗ and the observed values of
dYp, dEp and Zp; calculates the distribution of g({dYp−β∗dEp}) as induced by the distribution
in the right hand side of (2.3) and using, based on ignorability of the assignment Zp within pairs,
the probabilities pr(Zp = 1) = 0.5; and tests the hypothesized β∗ by testing, against that latter
distribution, the value of g({dYp − β∗dEp}) evaluated at the observed differences {dYp, dEp}.
For the function g, the study proposed a rank based statistic placing low weight on outliers.
Remark. While the above analysis is useful, it is not the only one that can address this design.
That study argued ((29), p. 75) that permutation as a mode of inference allows one to avoid
making assumptions such as monotonicity of Section 2.1, while such assumptions are required
by other modes of inference. However, a more careful examination of the above arguments
shows that it is the deterministic (and thus often implausible) aspect of the model (2.2), rather
than the permutation inference, that avoids making, for example, the monotonicity assumption.
To see this, note that when taking expectations of both sides of (2.3), first with respect to the
assignment given pair, and then over the larger population of pairs, we have that
E(dYp) = β E(dEp)
since the expectation of the right hand side of (2.3) is 0. So using the averages, over pairs,
of dYp and dEp to replace the expectations in the above expression gives an estimator that is
consistent for β and whose large sample properties are easy to derive with the delta method on
the ratio of averages. Thus inference with the model (2.2) can also be done without permutation
12
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arguments and without using a monotonicity assumption.
Likelihood inference.
The matched pairs of assignment design is also useful for cost reduction, and an example
is described in detail by Barnard et al. (11). The goal in that study was to assess the effect
that using school choice vouchers to attend private schools can have on children’s school per-
formance. For this question, directly comparing children who attend private choice schools
versus those who attend public schools is problematic due to the multitude of socioeconomic
and motivation factors that can be different between these two groups and that are difficult to
measure. To better evaluate the effect of school choice, the study designed and conducted a
randomized experiment in New York City. Funding for the experiment was provided for 1300
scholarships to low-income families to attend private schools. A randomized lottery deter-
mined the 1300 winning families whose children, among over 20 000 applicants, were offered
the scholarships. Children were then followed and evaluated with standardized tests at yearly
intervals; see Peterson and Howell (31) for an update.
Given the large number of children who did not win the scholarship, and the fixed budget
for the study, it was not feasible to follow all the children. For this reason, a matched pairs
of assignment design was considered for a subset of the children. Because the number of
covariates was fairly large, exact matching on all covariates was not possible. To address this,
the study estimated a propensity score (32) for the assignment to private schools (winning the
lottery) and used that to match each child who had been assigned to private school to a child
who not been so assigned. With this propensity score matched pairs design (33), although,
by randomization, the true propensity score is known and constant, matching in the estimated
propensity score generally increases efficiency compared to having selected a random subset
(34).
Two main issues make this study different from that of Rosenbaum (29). First, this study
13
Hosted by The Berkeley Electronic Press
had more than one factors that were partially controlled: compliance of children with the as-
signed vouchers, missingness in outcomes and missingness in covariates. For such cases, it has
been shown that using a standard instrumental variables approach is not appropriate to estimate
the effect of using vouchers on the outcomes (19). Details for how this can be addressed using
principal stratification are given in Barnard et al. (11).
The second main distinction is the role played by the matched pais of assignment in the
analysis. In the likelihood approach taken by Barnard et al. (11), as long as the variable used
to create the matched pairs – the estimated propensity score – is used in the models for the
potential outcomes and principal strata, the pairing of the design becomes ignorable in the
sense of Rubin (24). So, from this perspective, the main role of the design of the assignment is
to generate better data, i.e., that are more likely to produce more efficient estimates; but after
the data have been obtained, the ignorable design is not relevant in the inferential method.
The contrast between the above two examples for the design on matched pairs of assign-
ment emphasizes a trade-off in approaches to its analysis. First, data from this design can be
analysed with a likelihood model, although its adequancy is a concern and needs checking
as in other model settings. On the other hand, with a permutation approach, a deterministic
model between the potential outcomes and the principal strata as in model (2.2) seems central
for allowing exact calculation of the distribution of a pivotal quantity for the effect of interest.
Thus, although in partially controlled studies permutation inference could be advocated as a
means for avoiding model assumptions, it needs such and possibly even stronger assumptions
to address nuisance unknown quantities such as the values of the principal strata.
2.4 Unbalanced assignment and compliance subsampling designs
In randomized trials that a priori expect noncompliance to the treatment, conventional calcu-
lation of the sample size and the proportion of participants to be assigned to the experimental
14
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arm is based on a specified target value for the intention-to-treat effect, and on the properties of
intention-to-treat analyses. When the target estimand and analysis are different, such as those
described in Section 2.1, then the above calculations can be suboptimal. To address this, one
can obtain the relation of cost to precision for estimating the new target, and based on this
relation find a better design.
Jo ((35),(36)) explored this issue of cost in randomized trials where noncompliance is ex-
pected and is to be addressed with models for the template described in Section 2.1. The study
crossed different cost scenarios, depending on what cost is incurred by actually receiving the
assigned treatment, with scenarios of different fraction of participants in the experimental as-
signment and different expected conditions on compliance rate and outcome distributions. For
each scenario, the study calculated the total cost, over simulations, to have fixed power to detect
a specified target value for the effect of receiving treatment, δresponder. Estimation was based
on maximum likelihood of the model parameter corresponding to the estimand. The results
showed that to attain the same statistical power for estimating the effect of receiving treatment,
an appropriate unbalanced assignment design has usually lower cost than a balanced design.
The gains are increasing with increasing difference in the costs of treating individuals with the
experimental versus with the standard treatment.
In the above work, compliance behavior was considered to be measured for all units. For
situations when measuring compliance can be costly and optional, a general class of “compli-
ance sub-sampling”(CSS) designs has been proposed (37) that allows compliance information
to be measured for only subgroups of participants. Specifically, CSS allows the investigator
to choose on the total number of participants, the fractions assigned to experimental versus
standard treatment, and the fractions of participants for whom compliance will be measured in
the two assignment arms. These choices are allowed to depend on the cost parameters of the
study and the anticipated distributions of principal strata and potential outcomes. For each CSS
15
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design, that study developed expressions of the maximul likelihood estimator for the effect of
receiving treatment, δresponder, and derived the minimal-cost CSS design that achieves the
required precision for estimation. The study showed that the optimal design to balance total
cost with precision for estimating the effect of receiving treatment, is often a design that mea-
sures the compliance behavior for only representative subgroups in two unbalanced assignment
arms.
2.5 Clustered assignment design with individual noncompliance
When potential participants are part of clusters structure, a practical design can often be to
assign treatments by the clusters. Then, if participants comply differentially within and across
clusters, statistical methods need to address the combination of individual noncompliance with
the design effect of the clustered assignment.
An example of this clustered assignment with individual noncompliance was reported by
West et al. (38) and addressed as a partially controlled study by Korhonen et al. (39). The
original study’s goal was to examine if oral supplements of vitamin A could reduce infant mor-
tality in Nepal. A complete randomization of assignment of participants, as in Section 2.1, and
even of families, could be problematic in this case, for example, if families assigned to pills of
vitamin A would share pills with neighbouring families assigned placebo, leading to contam-
ination. To avoid such problems, the study randomized the assignment at the level of wards,
where all families within a ward were assigned the same treatment. Because subsequently the
treatment actually received was unknown for 13% of the children, Korhonen et al. (39) dis-
cussed estimation of the effect of taking vitamin A on survival under different hypotheses about
compliance.
The study defined the effect of taking vitamin A on survival by (a) assuming for all subjects
a survival time, Pi, that would have been observed had child i received no vitamin A; and
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(b) assuming that Pi equals to Y obsi exp(ψ0Eobsi ) in distribution, where Zi, Eobsi , and Y obsi are,
respectively, child i’s observed assignment, observed treatment received and observed survival
time after enrollment. Estimation was actually implemented using the stronger model:
log(Y obsi ) = log(Pi)− ψ Eobsi , (2.4)
for all individuals i, and inverting a test of independence between the treatment-free survival
{log(Pi)} and the randomized assignments {Zi} of treatment, adjusting for age at enrollment.
The design effect of clustering was addressed by constructing a robust estimate of the variance
of the estimate of the effect ψ0.
This approach can be connected to potential outcomes and principal strata, if we note that
model (2.4) can be viewed as arising from the following model,
log(Yi(z)) = log(Yi(0))− ψ Ei(z). (2.5)
for z = 0, 1 and all individuals i. Note also that it would be hard to justify assuming model
(2.4) for the observed data without the mechanism (2.5). This is because, model (2.4) does
not, in principle, preclude a study with just two participants (i = 1, 2) with exactly the same
potential outcomes and principal strata, i.e., Y1(z) = Y2(z) and E1(z) = E2(z) for z = 0, 1.
But then, making assumption (2.4) for both individuals, and simultaneously believing that (2.5)
is wrong would lead to a contradiction.
In this sense, then, models (2.4) and (2.5) are equivalent and the approach of estimation
by test inversion was, in the same spirit as Rosenbaum’s (2.2), except that here, estimation
was large-sample rather than permutation-based. An additional complication addressed in Ko-
rhonen et al. (39) was the censoring of the survival time for some participants. Clustered
assignment with individual noncompliance has also been addressed with random effects (40),
17
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(41).
3. Discussion and proposal for a broader class of designs
The reviewed designs allow deviations from the cohort completely randomized assignment
design, in order to either limit model dependency, such as with the matched pairs of assignment,
or to increase cost-effectiveness and practicality, such as with the unbalanced and clustered
designs.
These designs are, in most part, limited to exploration of different plans only of the assign-
ment of the controlled factor. In many instances, however, it would be important to be able to
use alternative designs that would explore aspects of the partially controlled factors or of the
outcome. For example, consider a study that has a relatively low variability in the observed
outcome, such as with low number of cases, i.e., participants who experience an event indi-
cated by Y obs = 1. Then, to limit influence of covariate models in outlying regions of the data,
we may want to consider a case-control design that would select data on all cases and only a
subset of controls (Y obs = 0) who would match the cases based on some rule using covari-
ates and possibly also the controlled and partially controlled factors. Although such “reduced”
designs are frequently used in simpler frameworks (e.g., case-control matching on covariates
with an ignorable treatment), they do not appear to have been used in any systematic way with
partially controlled studies, even among those that make the assumptions of Section 2.1. The
correspondence of analyses to the designs reviewed in the previous sections helps point at two
related reasons for this.
First, addressing a “reduced” design using the traditional equations of instrumental vari-
ables as a starting framework is complicated because these equations are posited in terms of
the observed controlled, partially controlled factor and outcomes. As Rubin (16) also observes,
these equations already tie together assumptions specific to each participant (e.g., exclusion)
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with assumptions of the design (e.g., some variant of the randomized assignment in the co-
hort). As a consequence, such equations cannot easily represent how assumptions on the ob-
served data are changed when changing to a more general design but keeping other participant-
specific assumptions the same. Weighting these estimating equations could theoretically lead
to estimation if the inverse weights reflect formally probabilities of selection to the “reduced”
design conditionally on the cohort. However, most often the selection rule conditionally on the
cohort sample is closer to a deterministic rather than to a probabilistic rule, for example when
choosing the control that most closely matches a case on some metric of other variables. Then,
probabilities of selection to the reduced sample are at the boundary and the weighting approach
is not useful.
On the other hand, using the framework of principal stratification as a starting point makes
clear separation of the design from the participant-specific assumptions. This separation makes
it relatively straightforward to calculate the likelihood of data from a “reduced” design, such
as a conditional likelihood for the above case-control design. But because causal effects in
this framework are defined based on the partially unobserved principal stratification, they are
generally not fully identifiable from the likelihood of “reduced” designs.
This suggests that a way to make use of “reduced” designs in partially controlled studies
is through a “polydesign”, that is, a combination of a reduced and the cohort designs in two
conceptual stages. In the first stage, a reduced design can be chosen so that its (conditional)
likelihood better focuses on a subset of the cohort data. This “reduced” design can then be used
to estimate the part of the causal effect that is identifiable from the “reduced” likelihood. If the
causal effect is fully identifiable from that likelihood, then estimation stops here. Otherwise,
in a second stage the cohort design is used to estimate the part of the causal effect that was not
identifiable from the reduced likelihood.
Estimation based on a polydesign is expected to have two general properties. First, esti-
19
Hosted by The Berkeley Electronic Press
mation of the causal effect is expected to be valid if the model for the cohort is valid. Second,
such estimation based on the polydesign is expected to be more robust than that using the full
cohort, for misspecification of aspects of the cohort model that are not fitted when using the
reduced likelihood in the polydesign. These two properties of polydesigns can be important
also in more demanding problems.
Although most partially controlled studies, including those reviewed above, make at least
some of the assumptions considered in Section 2.1, these assumptions may not always be plau-
sible. In such cases, it is important to also consider sensitivity to these assumptions for ex-
ample, in the sense of (43), (44) and (39). If such different assumptions are formulated in
terms of potential outcomes and principal strata, rather than in terms of the observed data, their
interpretation will be preserved across different designs or polydesigns.
Also, here we have formulated potential outcomes following the reasoning of Rubin (1978),
as explicit functions of only the factor for which there is sufficient understanding to treat it as
controlled. If similar understanding exists also for the other factors, which we treated here
as partially controlled, then, by the same reasoning, potential outcomes should be extended
to functions of both factors. For example, focus here has been on studies with single-time
administration of the controlled and partially controlled factors. However, many studies are
better formulated as longitudinal, which can be an especially fertile ground for polydesigns.
Continued research is needed in this area, but preliminary work (42) suggests that such an
approach can help better evaluate causal effects in partially controlled studies.
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Figure 1. Template of a treatment trial using principal stratification on gene expression and clin-
ical outcome. In the right side, “mix” indicates that observed outcome distributions, stratified
by observed treatment and gene expression level, are mixtures of potential outcome distribu-
tions across principal strata of gene expression shown in the left side.
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